[Home ] [Archive]    
:: Main :: About :: Current Issue :: Archive :: Search :: Submit :: Contact ::
Main Menu
Journal Information::
Articles archive::
Submission ::
Contact us::
Site Facilities::
Impact Factor
Impact Factor 2022: 1.9
5-Year Impact Factor: 2.2
Cite Score 2022: 3.9
SJR 2022: 0.447
SNIP 2022: 0.538

Publication Fee
Search in website

Advanced Search
Receive site information
Enter your Email in the following box to receive the site news and information.
:: Volume 2, Issue 3 (Int J Mol Cell Med 2013) ::
Int J Mol Cell Med 2013, 2(3): 99-109 Back to browse issues page
Embryological Aspects of Oocyte In Vitro Maturation
Mir Mehrdad Farsi1 , Nematollah Kamali2 , Mohsen Pourghasem 3
1- Fatemeh Zahra Infertility and Health Reproductive Research Center, Babol University of Medical Sciences, Babol, Iran.
2- Department of Anatomical Sciences, Babol University of Medical Sciences, Babol, Iran.
3- Cellular and Molecular Biology Research Center (CMBRC), Babol University of Medical Sciences, Babol, Iran. , mpourghasem@hotmail.com
Abstract:   (13142 Views)
In Vitro Maturation (IVM) is a method that immature oocytes in antral follicles are extracted and matured in laboratry conditions. This review has attempted to provide the current knowledge and recent findings in in vitro maturation of oocytes and highlights the most important factors involved in this process. The review is based on literature reports and the author’s experience. In IVM cycles, the time of administration of hCG is depending on the diameter of the largest follicle that has been determined to be about 10-12 mm to prevent the detrimental effect of dominant follicle (DF). Higher number of in vivo matured oocytes with dispersed cumulus cells (CC) pattern can be achieved by increasing the time of hCG injection up to 38 h. Growing of oocytes during the final hours of in vitro maturation has profound effect on the following outcome. Injection of IVM oocytes must be delayed at least 1 h after extrusion of the first polar body. IVM outcome shows that the pregnancy rate is low in pure immature oocytes except PCO(s) (Polycystic ovaries and Polycystic ovarian syndrome) cases. Furthermore, endometrial quality may have a crucial role in this respect after non hCG-triggered IVM. The formulation of different types of maturation media shows that they are generally supplemented with recombinant FSH and hCG. Taurine and calcium as unique components of blastocyst medium have been supposed to be valuable to IVM media. Pyruvate and adenosine triphosphate (ATP) and Epidermal Growth Factor (EGF) have been proposed as additives for maturation media. IVM is not a suitable treatment for women over 40 years. Different categories of patients could be candidate for IVM. Despite of old concept in low outcome and caution in IVM indications, innovative findings in this field have opened new windows in the treatment of patients.
Keywords: In Vitro Maturation, immature oocyte, follicle
Full-Text [PDF 113 kb]   (2827 Downloads)    
Type of Study: Review | Subject: Cell Biology
Received: 2013/05/21 | Accepted: 2013/08/28 | Published: 2013/08/28
Send email to the article author

Add your comments about this article
Your username or Email:


XML     Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Farsi M M, Kamali N, Pourghasem M. Embryological Aspects of Oocyte In Vitro Maturation. Int J Mol Cell Med 2013; 2 (3) :99-109
URL: http://ijmcmed.org/article-1-83-en.html

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Volume 2, Issue 3 (Int J Mol Cell Med 2013) Back to browse issues page
International Journal of Molecular and Cellular Medicine (IJMCM) International Journal of Molecular and Cellular Medicine (IJMCM)
Persian site map - English site map - Created in 0.05 seconds with 39 queries by YEKTAWEB 4639